Chilosi M, Gilioli E, Lestani M, Menestrina F, Fiore-Donati L
Istituto di Anatomia Patologica, University of Verona, Italy.
J Pathol. 1988 Nov;156(3):251-4. doi: 10.1002/path.1711560310.
In this study we provide evidence that MB1, a newly developed monoclonal antibody which reacts with B lymphocytes and a proportion of T cells and monocytes, can be successfully used for the direct immunohistochemical identification of osteoclasts on paraffin-embedded surgical specimens. The antigen(s) recognized by MB1 is present at high density in the cytoplasm of osteoclasts of fetal bone and in the multinucleated cells of human giant cell tumour of bone (osteoclastoma), but is weakly expressed or absent in the giant cells of granulomas. MB1 is thus proposed as a new immunohistochemical marker for osteoclasts on paraffin-embedded material.
在本研究中,我们提供了证据表明,MB1是一种新开发的单克隆抗体,可与B淋巴细胞、一部分T细胞和单核细胞发生反应,它能够成功用于在石蜡包埋的手术标本上直接免疫组织化学鉴定破骨细胞。MB1识别的抗原在胎儿骨破骨细胞的细胞质以及骨巨细胞瘤(破骨细胞瘤)的多核细胞中高密度存在,但在肉芽肿的巨细胞中表达较弱或不存在。因此,MB1被提议作为石蜡包埋材料上破骨细胞的一种新的免疫组织化学标志物。